Test Price
2,800 AED✅ Home Collection Available
TLL1 Gene Atrial Septal Defect Type 6 Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
This advanced next-generation sequencing (NGS) test identifies pathogenic variants in the TLL1 gene associated with atrial septal defect type 6 (ASD6). It delivers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited processing. The service includes VIP mobile phlebotomy with temperature-controlled cold-chain home collection (daily 8 AM–11 PM), post-test telephonic clinical guidance from a DHA-licensed genetics professional, and direct billing verification via WhatsApp +971 54 548 8731.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection (daily 8 AM–11 PM).
- Clinical Guidance: DHA-licensed genetics professional provides telephonic post-test interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing (NGS) test screens the entire coding region of the TLL1 gene for pathogenic variants implicated in atrial septal defect type 6 (ASD6), a congenital heart malformation with autosomal dominant inheritance. The assay provides comprehensive coverage for single nucleotide variants and small insertions/deletions, guiding surgical intervention or cardiac surveillance based on current clinical guidelines.
| Aspect | Our TLL1 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% analytical sensitivity for single nucleotide variants and small indels | ~99.0% sensitivity; limited to targeted exon |
| Methodology | NGS (Illumina NovaSeq), read depth >100x | Capillary electrophoresis; lower throughput |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
"The TLL1 genetic test is instrumental in confirming clinical suspicion of ASD6, but it must be interpreted alongside echocardiographic findings and comprehensive family history. I encourage every patient to discuss the implications of a positive result with a cardiologist and genetic counsellor before making any treatment decisions. This test is one piece of your cardiovascular puzzle, not the entire picture."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication Safety
Do not discontinue or alter prescribed medication without consulting your treating physician. The test results do not replace ongoing medical management.
Exclusion Criteria & Warning Signs
Safety Exclusion: This test is not suitable for asymptomatic minors without a confirmed family history of ASD6. Patients with active systemic infection or coagulopathy should defer blood collection. ER Red Flags: If you experience sudden chest pain, syncope, or severe dyspnea, seek immediate medical attention – these may indicate cardiac decompensation unrelated to the test procedure.
Patient FAQ & Clinical Guidance
1. How accurate is the TLL1 gene test for confirming atrial septal defect type 6?
Our NGS assay detects pathogenic variants with 99.9% sensitivity, making it the most reliable molecular diagnostic tool for ASD6 when correlated with cardiac imaging and clinical findings.
2. How long does it take to get results for the TLL1 genetic test in the UAE?
The complete genetic test result is available within 3 to 4 weeks from sample receipt, issued in a DHA-accredited laboratory report.
3. Can I use my health insurance to cover the AED 2,800 cost?
Most UAE insurers cover genetic testing when medically justified. Our team verifies your coverage instantly via WhatsApp at +971 54 548 8731 and submits direct billing claims.
4. Do I need to fast before the blood draw?
No fasting is required for this genetic test. A standard blood sample (EDTA tube) is collected at your convenience.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability regarding patient safety and informed consent. The laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | TLL1 Gene Atrial Septal Defect Type 6 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral blood (whole blood, EDTA tube) |
| Methodology Used | NGS (Illumina NovaSeq), read depth >100x |
| ICD-10-CM Code | Q21.1 (Atrial septal defect) |
| LOINC Code | 55233-1 (Genetic testing) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians